China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025 
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report 
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths 
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates 
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
EU Recovery Fund Faces Bottlenecks Despite Driving Digital and Green Projects 
Oil Prices Steady as Markets Weigh U.S.-Iran Talks, Dollar Strength Caps Gains 
Jerome Powell Attends Supreme Court Hearing on Trump Effort to Fire Fed Governor, Calling It Historic 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
China and Uruguay Strengthen Strategic Partnership Amid Shifting Global Order 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case 
Oil Prices Slide Nearly 3% as U.S.-Iran Talks Ease Geopolitical Tensions 
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash 
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer 
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI 
The U.S. House of Representatives passed a bill entitled Marijuana Opportunity Reinvestment and Expungement (MORE) Act to end the federal ban on marijuana, though the measure was seen as unlikely to pass the Senate.
The bill sponsored by Democratic Representative Jerrold Nadler of New York, passed by 220-204, with few Republicans supporting the measure.
The bill decriminalizes marijuana cultivation, distribution, and possession by removing it from the list of controlled narcotics.
However, the MORE Act will need 60 votes in the Senate's evenly divided chamber to reach President Joe Biden's desk for signature, a result largely considered implausible given the measure's lack of Republican support.
Democratic Representative Ed Perlmutter stated on the House floor on Thursday ahead of the vote that the bill will "end decades of failing and unfair marijuana prohibition." He added Prohibition is clearly past, and today we have a chance to create a new route forward on federal cannabis legislation that makes sense."
He went on to say that the bill does not compel any state to legalize marijuana.
Marijuana consumers and companies in the United States face a convoluted legal landscape, with 37 states legalizing it in some form, whether for recreational or medical purposes and 13 states still outright prohibiting it.
Researchers are severely constrained in their ability to study cannabis and its effects due to federal law's classification of the drug as an illicit drug with no medicinal uses, making the policy difficult to design.
Because of the federal ban, cannabis firms are mainly excluded from the banking system in the United States.
On the House floor, Republican Representative Michelle Fischbach said that the bill was "not just defective, but dangerous," because it would not protect minors and would encourage people to start marijuana enterprises.
Marijuana legalization is exceedingly popular among Americans, with 91 percent agreeing that either medical or recreational use should be permitted, according to a Pew Research Center poll conducted in 2021.
Senate Majority Leader Chuck Schumer, a Democrat, came up with his marijuana-legalization bill, which he plans to introduce in April.
